Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 47 | $54,116,389 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Aug 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 30 Aug 2024 | Sale | 6,193 | 73.3232 | 454,091 | D |
| 30 Aug 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 30 Aug 2024 | Sale | 28,203 | 72.732 | 2,051,261 | D |
| 30 Aug 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 29 Aug 2024 | Sale | 5,772 | 73.2451 | 422,771 | D |
| 30 Aug 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 29 Aug 2024 | Sale | 29,832 | 72.4428 | 2,161,114 | D |
| 28 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 28 Aug 2024 | Sale | 240 | 73.7 | 17,688 | D |
| 28 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 28 Aug 2024 | Sale | 32,459 | 72.7414 | 2,361,113 | D |
| 28 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 27 Aug 2024 | Sale | 16,856 | 73.9316 | 1,246,191 | D |
| 28 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 26 Aug 2024 | Sale | 22,713 | 74.5929 | 1,694,229 | D |
| 28 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 27 Aug 2024 | Sale | 23,657 | 73.3341 | 1,734,865 | D |
| 23 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 23 Aug 2024 | Sale | 28,680 | 74.4573 | 2,135,435 | D |
| 23 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 22 Aug 2024 | Sale | 4,369 | 75.4697 | 329,727 | D |
| 23 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 22 Aug 2024 | Sale | 35,011 | 74.5787 | 2,611,075 | D |
| 23 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 21 Aug 2024 | Sale | 1,900 | 77.9805 | 148,163 | D |
| 23 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 21 Aug 2024 | Sale | 4,297 | 76.2001 | 327,432 | D |
| 23 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 21 Aug 2024 | Sale | 2,682 | 77.2139 | 207,088 | D |
| 23 Aug 2024 18:00 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman and CEO | 21 Aug 2024 | Sale | 44,134 | 75.4026 | 3,327,818 | D |
| 11 Mar 2024 20:33 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 11 Mar 2024 | Sale | 306 | 67.33 | 20,603 | D |
| 11 Mar 2024 20:33 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 11 Mar 2024 | Sale | 1,590 | 66.81 | 106,228 | D |
| 11 Mar 2024 20:33 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 11 Mar 2024 | Sale | 4,128 | 65.9 | 272,035 | D |
| 11 Mar 2024 20:33 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 11 Mar 2024 | Sale | 14,541 | 64.8 | 942,257 | D |
| 11 Mar 2024 20:33 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 07 Mar 2024 | Sale | 8,754 | 66.93 | 585,905 | D |
| 11 Mar 2024 20:33 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 07 Mar 2024 | Sale | 31,958 | 66.38 | 2,121,372 | D |
| 27 Feb 2024 19:59 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 26 Feb 2024 | Sale | 12,462 | 70.11 | 873,711 | D |
| 27 Feb 2024 19:59 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 26 Feb 2024 | Sale | 9,528 | 69.45 | 661,720 | D |
| 27 Feb 2024 19:59 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 26 Feb 2024 | Sale | 600 | 68.39 | 41,034 | D |
| 05 Feb 2024 18:10 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 02 Feb 2024 | Sale | 17,450 | 67.42 | 1,176,479 | D |
| 05 Feb 2024 18:10 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 02 Feb 2024 | Sale | 16,435 | 66.7 | 1,096,214 | D |
| 18 Jan 2024 19:47 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 18 Jan 2024 | Sale | 320 | 66.25 | 21,200 | D |
| 18 Jan 2024 19:47 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 18 Jan 2024 | Sale | 67,597 | 65.19 | 4,406,648 | D |
| 18 Jan 2024 19:47 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 17 Jan 2024 | Sale | 17,451 | 66.66 | 1,163,284 | D |
| 18 Jan 2024 19:47 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 17 Jan 2024 | Sale | 30,633 | 66 | 2,021,778 | D |
| 18 Jan 2024 19:47 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 16 Jan 2024 | Sale | 5,882 | 67.76 | 398,564 | D |
| 18 Jan 2024 19:47 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 16 Jan 2024 | Sale | 65,979 | 67.25 | 4,437,088 | D |
| 18 Jan 2024 19:47 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 16 Jan 2024 | Sale | 3,500 | 66.38 | 232,330 | D |
| 19 Sep 2023 20:40 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 19 Sep 2023 | Sale | 44,413 | 54.17 | 2,405,852 | D |
| 19 Sep 2023 20:40 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 18 Sep 2023 | Sale | 28,119 | 53.96 | 1,517,301 | D |
| 19 Sep 2023 20:40 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 18 Sep 2023 | Sale | 27,468 | 53.55 | 1,470,911 | D |
| 13 Mar 2023 19:31 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 13 Mar 2023 | Sale | 1,412 | 44.08 | 62,241 | D |
| 13 Mar 2023 19:31 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 13 Mar 2023 | Sale | 19,153 | 45.06 | 863,034 | D |
| 13 Mar 2023 19:31 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 10 Mar 2023 | Sale | 6,805 | 42.51 | 289,281 | D |
| 13 Mar 2023 19:31 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 10 Mar 2023 | Sale | 34,965 | 43.28 | 1,513,285 | D |
| 27 Feb 2023 19:59 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 24 Feb 2023 | Sale | 22,590 | 47.03 | 1,062,408 | D |
| 22 Feb 2023 20:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 21 Feb 2023 | Sale | 251 | 49.6 | 12,450 | D |
| 22 Feb 2023 20:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 21 Feb 2023 | Sale | 2,502 | 48.7 | 121,847 | D |
| 22 Feb 2023 20:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 21 Feb 2023 | Sale | 2,200 | 47.35 | 104,170 | D |
| 22 Feb 2023 20:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 21 Feb 2023 | Sale | 22,895 | 46.54 | 1,065,533 | D |
| 15 Dec 2022 19:01 | ITCI | Intra-Cellular Therapies Inc | MATES SHARON | Chairman, President & CEO | 13 Dec 2022 | Sale | 33,083 | 55 | 1,819,565 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)